课题基金 / 基金详情

Molecular cell biology of MHC class I retention by the gp40 protein of the murine cytomegalovirus

Molecular cell biology of MHC class I retention by the gp40 protein of the murine cytomegalovirus
鼠巨细胞病毒 gp40 蛋白保留 MHC I 类的分子细胞生物学
批准号:
287481932
负责人:
Professor Dr. Sebastian Springer
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2015
资助国家:
德国
项目状态:
已结题
起止时间:
2014-12-31 至 2020-12-31

项目摘要

项目成果

Professor Dr. Sebastian Springer的其他基金

相似基金

相关文献

中文摘要
翻译
主要组织相容性复合体(MHC)I类分子通过将病毒抗原呈递给细胞表面的细胞毒性T淋巴细胞,从而导致感染细胞的凋亡,从而控制感染,在抗病毒免疫反应中发挥关键作用。因此,许多病毒已经开发出避开MHC I类分子识别的策略来持续存在也就不足为奇了:存在着大量干扰抗原提呈的病毒蛋白,即所谓的免疫转运蛋白。我们一直在研究小鼠巨细胞病毒(MCMV)的免疫eVasin gp40,发现它的作用方式不同于其他免疫eVasin:它与MHC I类分子结合,但与其他直接相互作用的免疫eVasin不同,它不会导致它们的降解,相反,完全成熟的I类分子保留在无法到达细胞表面的分泌途径的早期隔室。我们进一步鉴定了gp40中一个新的序列,连接子,它是保持自身和MHC I类分子之一所必需的。这些数据已经汇总在一份手稿中,不久将提交出版。在这个项目中,我们将研究gp40介导的I类细胞内滞留的先决条件,即gp40本身在细胞内的滞留:我们将描述发生的滞留类型,确定连接序列在保留过程中的功能,并确定gp40可能调节gp40滞留的潜在结合伙伴,从而确定其功能。我们还将详细研究gp40和I类分子在活细胞中的相互作用。对gp40滞留的更深刻理解将有助于阐明病毒免疫逃避策略的多样性,这些策略是导致终生病毒持续存在的原因。
英文摘要
MHC (major histocompatibility complex) class I molecules play a key role in the anti-viral immune response by presenting viral antigens to cytotoxic T lymphocytes at the cell surface, which leads to apoptosis of the infected cell and to the control of infection. It is therefore not astonishing that many viruses have developed strategies to circumvent recognition by MHC class I molecules in order to persist: A vast number of viral proteins exist that interfere with antigen presentation, the so-called immunoevasins. We have been studying the immunoevasin gp40 of the murine cytomegalovirus (MCMV) and found out that its mode of action differs from that one of other immunoevasins: It binds to MHC class I molecules but, unlike other immunoevasins that interact directly, it does not lead to their degradation, instead, fully mature class I molecule are retained in an early compartment of the secretory pathway unable to reach the cell surface. We have further identified a novel sequence in gp40, the linker, which is required for both its own retention and that one of MHC class I molecules. These data are already summarized in a manuscript and will be submitted to publication soon. In this project, we will investigate the prerequisite for gp40-mediated class I intracellular retention, namely, the intracellular retention of gp40 itself: We will describe the kind of retention taking place, determine the function of the linker sequence in the retention process, and identify potential binding partners of gp40 that might regulate gp40 retention and, hence, its function. We will also investigate in detail the interaction between gp40 and class I in live cells. A more profound understanding of gp40 retention will help to shed light on the diversity of viral immune evasion strategies that are responsible for lifelong viral persistence.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Small molecules to manipulate peptide binding to MHC class I molecules, an optimized method for the generation of MHC tetramers by peptide exchange
  • 批准号:
    310813447
  • 项目类别:
    Research Grants (Transfer Project)
  • 资助金额:
    $0.0万
  • 财政年份:
    2016
  • 负责人:
    Professor Dr. Sebastian Springer
  • 依托单位:
Endocytic sorting of MHC class I molecules
  • 批准号:
    190867601
  • 项目类别:
    Research Grants
  • 资助金额:
    $0.0万
  • 财政年份:
    2011
  • 负责人:
    Professor Dr. Sebastian Springer
  • 依托单位:
Enhancement of peptide binding to MHC class I molecules by small compounds - a combined biochemical and computational investigation
国内基金
海外基金
全细胞疫苗Cell@MnO2的乳腺癌术后免疫响应监测与放射免疫治疗研究
  • 批准号:
    QN25H220002
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    顾媛
  • 依托单位:
染色体外环状DNA以cell-in-cell途径促进基因横向传递和扩增的研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    15.0万元
  • 批准年份:
    2024
  • 负责人:
    王锐智
  • 依托单位:
GMFG/F-actin/cell adhesion 轴驱动 EHT 在造 血干细胞生成中的作用及机制研究
  • 批准号:
    TGY24H080011
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    李鸿鹄
  • 依托单位:
糖尿病ED中成纤维细胞衰老调控内皮细胞线粒体稳态失衡的机制研究
  • 批准号:
    82371634
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    赵福军
  • 依托单位: